Cancer immunoinformatics: a new assistant tool for malignant disease research

Objective To introduce the recent developments in cancer immunoinformatics with an emphasis on the latest trends and future direction. Data sources All related articles in this review were searched from PubMed published in English from 1992 to 2013. The search terms were cancer, immunoinformatics, immunological databases, and computational vaccinology. Study selection Original articles and reviews those were related to application of cancer immunoinformatics about tumor basic and clinical research were selected. Results Cancer immunoinformatics has been widely researched and applied in a series of fields of cancer research, including computational tools for cancer, cancer immunological databases, computational vaccinology, and cancer diagnostic workflows. Furthermore, the improvement of its theory and technology brings an enlightening insight into understanding and researching cancer and helps expound more deep and complete mechanisms of tumorigenesis and progression. Conclusion Cancer immunoinformatics provides promising methods and novel strategies for the discovery and development of tumor basic and clinical research.

[1]  R. Montañez,et al.  Information integration of protein-protein interactions as essential tools for immunomics. , 2006, Cellular immunology.

[2]  S. Ribeiro,et al.  CD4+ T Cell Epitope Discovery and Rational Vaccine Design , 2010, Archivum Immunologiae et Therapiae Experimentalis.

[3]  Marie-Paule Lefranc,et al.  IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis , 2008, Nucleic Acids Res..

[4]  V. Wiwanitkit.  Cancer immunomics and application of ‘omics’ for cancer management , 2007, Expert review of clinical immunology.

[5]  D. Lauffenburger,et al.  Applying computational modeling to drug discovery and development. , 2006, Drug discovery today.

[6]  Vito Michele Fazio,et al.  Epitope-driven DNA vaccine design employing immunoinformatics against B-cell lymphoma: a biotech's challenge. , 2012, Biotechnology advances.

[7]  Irini Doytchinova,et al.  T-cell epitope vaccine design by immunoinformatics , 2013, Open Biology.

[8]  M. Disis,et al.  Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of concept. , 2011, Omics : a journal of integrative biology.

[9]  J. Rice,et al.  DNA Fusion Vaccine Designed to Induce Cytotoxic T Cell Responses Against Defined Peptide Motifs: Implications for Cancer Vaccines1 , 2001, The Journal of Immunology.

[10]  Ferdinando Chiacchio,et al.  Cancer Vaccines: State of the Art of the Computational Modeling Approaches , 2012, BioMed research international.

[11]  S. J. H. do Monte,et al.  Immunoproteomics and immunoinformatics analysis of Cryptococcus gattii: novel candidate antigens for diagnosis. , 2013, Future microbiology.

[12]  Vladimir Brusic,et al.  Virtual models of the HLA class I antigen processing pathway. , 2004, Methods.

[13]  D. DeLuca,et al.  The immunoinformatics of cancer immunotherapy. , 2007, Tissue antigens.

[14]  J. Söllner,et al.  Concept and application of a computational vaccinology workflow , 2010, Immunome research.

[15]  M. Cancro,et al.  Screening of alternative models for transitional B cell maturation. , 2004, International immunology.

[16]  P E Seiden,et al.  A model for simulating cognate recognition and response in the immune system. , 1992, Journal of theoretical biology.

[17]  Rob J. De Boer,et al.  MHC polymorphism under host-pathogen coevolution , 2004, Immunogenetics.

[18]  V. Fazio,et al.  Genetic Immunization with CDR3-Based Fusion Vaccine Confers Protection and Long-Term Tumor-Free Survival in a Mouse Model of Lymphoma , 2010, Journal of biomedicine & biotechnology.

[19]  D. Seripa,et al.  Anti-tumor immunity induced by CDR3-based DNA vaccination in a murine B-cell lymphoma model. , 2008, Biochemical and biophysical research communications.

[20]  Tin Wee Tan,et al.  Methods and protocols for prediction of immunogenic epitopes , 2006, Briefings Bioinform..

[21]  Alessandro Sette,et al.  The Immune Epitope Database 2.0 , 2009, Nucleic Acids Res..

[22]  Christina Backes,et al.  Integrative analysis of cancer‐related data using CAP , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  C. Ottensmeier,et al.  DNA fusion gene vaccines against cancer: from the laboratory to the clinic , 2004, Immunological reviews.

[24]  Badal Joshi,et al.  On immunotherapies and cancer vaccination protocols: a mathematical modelling approach. , 2009, Journal of theoretical biology.

[25]  Antoni Ribas,et al.  Targeted Therapies to Improve Tumor Immunotherapy , 2008, Clinical Cancer Research.

[26]  Joo Chuan Tong,et al.  Immunoinformatics: Current trends and future directions , 2009, Drug Discovery Today.

[27]  Seema Mishra,et al.  Immunoinformatics and Modeling Perspective of T Cell Epitope-Based Cancer Immunotherapy: A Holistic Picture , 2009, Journal of biomolecular structure & dynamics.

[28]  G. Saglio,et al.  Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells. , 2001, Cancer research.

[29]  Marie-Paule Lefranc,et al.  IMGT/3Dstructure-DB and IMGT/StructuralQuery, a database and a tool for immunoglobulin, T cell receptor and MHC structural data , 2004, Nucleic Acids Res..

[30]  Fernando Pereira,et al.  An automated procedure to identify biomedical articles that contain cancer‐associated gene variants , 2006, Human mutation.

[31]  Nikolai Petrovsky,et al.  Immunome Research , 2005, Immunome research.

[32]  Zhenxing Li,et al.  Mapping IgE binding epitopes of major shrimp (Penaeus monodon) allergen with immunoinformatics tools. , 2011, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[33]  G. Li Pira,et al.  High Throughput T Epitope Mapping and Vaccine Development , 2010, Journal of biomedicine & biotechnology.

[34]  R. Zinkernagel,et al.  Uncertainties − discrepancies in immunology , 2002, Immunological reviews.

[35]  Benjamin Schubert,et al.  miHA-match: computational detection of tissue-specific minor histocompatibility antigens , 2012, BCB.

[36]  J. Grassi,et al.  Enhancement of antibody responses in DNA vaccination using a vector encoding a universal T-helper cell epitope. , 2004, DNA and cell biology.

[37]  Srinivasan Ramachandran,et al.  Computer-aided biotechnology: from immuno-informatics to reverse vaccinology. , 2008, Trends in biotechnology.

[38]  B. Williams,et al.  Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer , 2008, Cancer Immunology, Immunotherapy.

[39]  S. Rosenberg,et al.  Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.

[40]  R. Houot,et al.  Vaccines for lymphomas: idiotype vaccines and beyond. , 2009, Blood reviews.

[41]  Quentin Kaas,et al.  IG, TR and IgSF, MHC and MhcSF: what do we learn from the IMGT Colliers de Perles? , 2008, Briefings in functional genomics & proteomics.

[42]  G. Winberg,et al.  Signal sequence deletion and fusion to tetanus toxoid epitope augment antitumor immune responses to a human carcinoembryonic antigen (CEA) plasmid DNA vaccine in a murine test system , 2003, Cancer Gene Therapy.

[43]  Carole A. Goble,et al.  Opening new gateways to workflows for life scientists , 2012, HealthGrid.